Literature DB >> 22802577

Racial differences in parathyroid hormone levels in CKD.

Tamara Isakova1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22802577      PMCID： PMC3398065          DOI： 10.1093/ndt/gfs173

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  18 in total

1.  Demographic, dietary, and serum factors and parathyroid hormone in the National Health and Nutrition Examination Survey.

Authors:  J M Paik; W R Farwell; E N Taylor
Journal:  Osteoporos Int       Date:  2011-09-20       Impact factor: 4.507

Review 2.  PTH--a particularly tricky hormone: why measure it at all in kidney patients?

Authors:  Giorgia Garrett; Sunita Sardiwal; Edmund J Lamb; David J A Goldsmith
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-08       Impact factor: 8.237

3.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

4.  Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

Authors:  Daniel E Weiner; Hocine Tighiouart; Manish G Amin; Paul C Stark; Bonnie MacLeod; John L Griffith; Deeb N Salem; Andrew S Levey; Mark J Sarnak
Journal:  J Am Soc Nephrol       Date:  2004-05       Impact factor: 10.121

5.  Serum phosphate levels and mortality risk among people with chronic kidney disease.

Authors:  Bryan Kestenbaum; Joshua N Sampson; Kyle D Rudser; Donald J Patterson; Stephen L Seliger; Bessie Young; Donald J Sherrard; Dennis L Andress
Journal:  J Am Soc Nephrol       Date:  2004-12-22       Impact factor: 10.121

6.  Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD.

Authors:  Jennifer Ennis; Elaine Worcester; Fredric Coe
Journal:  Nephrol Dial Transplant       Date:  2012-04-13       Impact factor: 5.992

7.  Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.

Authors:  Tamara Isakova; Patricia Wahl; Gabriela S Vargas; Orlando M Gutiérrez; Julia Scialla; Huiliang Xie; Dina Appleby; Lisa Nessel; Keith Bellovich; Jing Chen; Lee Hamm; Crystal Gadegbeku; Edward Horwitz; Raymond R Townsend; Cheryl A M Anderson; James P Lash; Chi-Yuan Hsu; Mary B Leonard; Myles Wolf
Journal:  Kidney Int       Date:  2011-03-09       Impact factor: 10.612

8.  Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries.

Authors:  Jay L Xue; Paul W Eggers; Lawrence Y Agodoa; Robert N Foley; Allan J Collins
Journal:  J Am Soc Nephrol       Date:  2007-02-28       Impact factor: 10.121

9.  Evidence for alteration of the vitamin D-endocrine system in blacks.

Authors:  N H Bell; A Greene; S Epstein; M J Oexmann; S Shaw; J Shary
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

10.  Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease.

Authors:  O M Gutiérrez; T Isakova; D L Andress; A Levin; M Wolf
Journal:  Kidney Int       Date:  2008-02-06       Impact factor: 10.612
View more
  5 in total

1.  Parathyroid hormone and the risk of incident hypertension: the Atherosclerosis Risk in Communities study.

Authors:  Lu Yao; Aaron R Folsom; James S Pankow; Elizabeth Selvin; Erin D Michos; Alvaro Alonso; Weihong Tang; Pamela L Lutsey
Journal:  J Hypertens       Date:  2016-02       Impact factor: 4.844

2.  Oral Cholecalciferol Supplementation in Sahara Black People with Chronic Kidney Disease Modulates Cytokine Storm, Oxidative Stress Damage and Athero-Thromboembolic Risk.

Authors:  Houda Zoubiri; Amina Tahar; Samir AitAbderrhmane; Messaoud Saidani; Elhadj-Ahmed Koceir
Journal:  Nutrients       Date:  2022-05-29       Impact factor: 6.706

3.  Serum calcium and incident type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Mary R Rooney; James S Pankow; Shalamar D Sibley; Elizabeth Selvin; Jared P Reis; Erin D Michos; Pamela L Lutsey
Journal:  Am J Clin Nutr       Date:  2016-08-10       Impact factor: 7.045

4.  Association between Parathyroid Hormone, 25 (OH) Vitamin D, and Chronic Kidney Disease: A Population-Based Study.

Authors:  Wei-Hao Wang; Li-Wei Chen; Chin-Chan Lee; Chiao-Yin Sun; Yu-Chiau Shyu; Heng-Rong Hsu; Rong-Nang Chien; I-Wen Wu
Journal:  Biomed Res Int       Date:  2017-03-07       Impact factor: 3.411

5.  Modulation of cardiometabolic risk and CardioRenal syndrome by oral vitamin D3 supplementation in Black and White Southern Sahara residents with chronic kidney disease Stage 3: focus on racial and ethnic disparities.

Authors:  Asma Bouazza; Amina Tahar; Samir AitAbderrhmane; Messaoud Saidani; Elhadj-Ahmed Koceir
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.